Australian playwright Melanie Tait receives the 2026 Suzie Miller Award, beginning a new chapter at Griffin Theatre Company with a residency exploring theatre and medical ethics.
On a quiet street in Sydney’s inner west, theatre often begins long before the curtain rises.
Inside Griffin Theatre Company, scripts arrive as loose pages, ideas scribbled in notebooks, conversations that stretch late into the evening. It is a place where Australian stories are tested and reshaped, sometimes over years, before they reach an audience.
Now another voice is stepping into that process.
Australian playwright and journalist Melanie Tait has been announced as the recipient of the 2026 Suzie Miller Award – a two-year residency and commission designed to give mid-career writers time, space and mentorship to develop new theatre.
For Tait, whose work often explores the peculiar rhythms of Australian life, the award marks the beginning of a quieter phase of creation. The applause will come later. For now, the work begins in rehearsal rooms and long writing days, where a new play slowly finds its shape.
Melanie Tait And The Path To The Suzie Miller Award
For many audiences, Melanie Tait’s work has already travelled widely.
Her plays have appeared on stages across Australia and beyond, often drawing from the small communities and everyday tensions that sit beneath the surface of Australian life. In The Appleton Ladies’ Potato Race, a seemingly modest dispute over a rural competition becomes a broader meditation on gender, tradition and belonging.
Another play, The Queen’s Nanny, offers a glimpse into the lesser-known corners of royal history, exploring the life of Marion Crawford – a governess whose story quietly intersects with the British monarchy.
Tait’s voice has also extended beyond theatre. As a journalist and commentator, she has written for the Australian Broadcasting Corporation and Guardian Australia, shifting between storytelling forms with an ear for human detail.
The Suzie Miller Award recognises precisely that kind of career – writers who have already contributed to Australian theatre but who are still shaping the next phase of their work.
For Tait, the opportunity brings both support and expectation: a $30,000 commission and two years embedded within Griffin’s creative environment.
Melanie Tait And The Creative Life Of Griffin Theatre
Few theatre companies in Australia are as closely associated with new writing as Griffin.
Since the late twentieth century, the company has developed and premiered plays that explore Australian identity with curiosity and sometimes uncomfortable honesty. The venue itself is modest – an intimate theatre overlooking Sydney Harbour – yet its influence reaches far beyond its walls.
Within that setting, Melanie Tait will spend the next two years developing a new work that engages with medical ethics, specifically within the field of brain cancer science.
It is a subject that may seem distant from the rural comedy of her earlier plays, yet the shift reflects the broader purpose of the Suzie Miller Award: encouraging writers to take risks.
The award is named after Australian playwright Suzie Miller, whose work has explored legal systems, morality and social responsibility with international impact. Her play Prima Facie has travelled from Sydney to London’s West End and Broadway, reaching audiences across the world.
Miller’s involvement in the award goes beyond naming rights. She mentors the recipient directly, offering dramaturgical guidance as the new play develops.
For Tait, that relationship creates a rare kind of apprenticeship within contemporary theatre – one writer guiding another through the long process of turning research into performance.
Melanie Tait And The Work Of Writing
A theatre residency rarely looks dramatic from the outside.
Most days unfold quietly: research notes spread across a desk, conversations with scientists or doctors, early drafts that will likely never reach the stage. Scenes are written and rewritten, characters appearing slowly through dialogue.
In Tait’s case, the research will lead into the complex world of brain cancer science – a field where medical breakthroughs and ethical questions often exist side by side.
Theatre has long explored such dilemmas, but the challenge lies in translating them into human stories.
The Griffin residency allows time for precisely that process. Alongside writing, Tait will mentor emerging playwrights through Griffin Studio, judge submissions for the Griffin Award and contribute to the company’s annual programming discussions.
In this way, the residency becomes less about a single script and more about participation in the wider creative ecology of Australian theatre.
Melanie Tait Among A New Generation Of Australian Playwrights
The announcement of Melanie Tait as the Suzie Miller Award recipient arrives alongside recognition for another writer.
Award-winning playwright and screenwriter Vanessa Bates has also received a commission to develop a new play examining the life and political influence of Junie Morosi, a figure whose story intersects with a complex chapter of Australian political history.
Together, the projects reflect the range of contemporary theatre: one exploring science and ethics, the other revisiting political memory.
For Griffin Theatre Company, supporting both writers continues a long tradition of nurturing Australian voices at different stages of their careers.
Mid-career playwrights often exist in a difficult space – experienced enough to carry a body of work, yet rarely afforded the financial or creative freedom granted to emerging or internationally established artists.
The Suzie Miller Award was created partly to address that gap.
Event And Program Details
2026 Suzie Miller Award Residency Announcement
Recipient: Melanie Tait
Griffin Theatre Company
Residency period: 2026–2027
Commission: Development of a new play exploring medical ethics in brain cancer science
Official information: https://griffintheatre.com.au